ArticleAmerican journal of public health2010
Global inequality in eye health: country-level analysis from the Global Burden of Disease Study.
Article in American journal of public health, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 50 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
50 citing papers in PubMed, 2 syntheses or guidelines pooled it, 134 citations in OpenAlex.
- Body mass index and risk of age-related cataract: a meta-analysis of prospective cohort studies.PloS one · 2014Pooled it
- Pooled it
- Clinic-based prevalence of uncorrected refractive errors and associated visual impairment: a nationwide cross-sectional study of 3.6 million outpatients in Mexico.BMC public health · 2026Article
- Global, regional and national burden of glaucoma from 1990 to 2021 and projections to 2050: a retrospective cross-sectional study.BMJ open · 2026Article
- Effective Cataract Surgery Coverage and Potential Influencing Factors for Adults in Fujian, Southeast of China: Fujian Eye Study.BioMed research international · 2026Article
- Article
- Global trends and disparities in burden of blindness and vision loss caused by non-communicable diseases from 1990 to 2021, and forecasts to 2045: a systematic analysis for the global burden of disease study 2021.Frontiers in medicine · 2025Article
- Global, regional and national patterns and gender disparity of intraocular foreign bodies from 1990 to 2021.Frontiers in public health · 2025Article
- Tools and methods for cataract recognition in low-resource settings: A narrative review.PLOS global public health · 2025Review
- The burden of vision loss due to cataract in China: findings from the Global Burden of Disease Study 2019.Eye (London, England) · 2024Article
- Changing Trends in the Global Burden of Cataract Over the Past 30 Years: Retrospective Data Analysis of the Global Burden of Disease Study 2019.JMIR public health and surveillance · 2023Article
- Risk factors associated with elevated intraocular pressure: a population-based study in a rural community of Bangladesh.BMJ open ophthalmology · 2023Article
- Current microfluidic platforms for reverse engineering of cornea.Materials today. Bio · 2023Review
- A National Registry-Based Epidemiological Study to Evaluate 395 646 Patients Hospitalized Due to Eye Diseases in Poland in 2019.Medical science monitor : international medical journal of experimental and clinical research · 2023Article
- The national, regional, and global impact of glaucoma as reported in the 2019 Global Burden of Disease Study.Archives of medical science : AMS · 2023Article
- Time trends and gender disparities of Chinese cataract burden and their predictions.International journal of ophthalmology · 2023Article
- Uncorrected refractive errors are important causes of avoidable visual impairment in Hungary: re-evaluation of two existing national data sets.International journal of ophthalmology · 2023Article
- Anticataract Effect of the Aqueous Extract of the Flowers ofAdvances in pharmacological and pharmaceutical sciences · 2023Article
- Global, regional, national burden and gender disparity of cataract: findings from the global burden of disease study 2019.BMC public health · 2022Article
- Evaluation of Topical and Subconjunctival Injection of Hyaluronic Acid-Coated Nanoparticles for Drug Delivery to Posterior Eye.Pharmaceutics · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesWe assessed global inequality in eye health by using data on the global burden of disease measured in disability-adjusted life years (DALYs).
methodsWe estimated the burden of eye disease by calculating the sum of DALYs (from the Global Burden of Disease study, 2004 update) due to trachoma, vitamin A deficiency, glaucoma, cataract, refractive errors, and macular degeneration. We assessed the geographic distribution of eye disease in relation to economic status and etiology by calculating the Gini coefficient, the Theil index, and the Atkinson index.
resultsThe global burden of eye disease was estimated at 61.4 million DALYs worldwide (4.0% of total DALYs). Vitamin A deficiency and trachoma were distributed more unevenly than were noncommunicable eye diseases, regardless of economic status. For noncommunicable eye diseases, the major contributor was refractive errors, regardless of economic status. The most uneven distribution was observed for cataract (high-income countries) and refractive errors (middle- and low-income countries).
conclusionsCreating new eye health service for refractive errors and reducing the unacceptable eye health disparity in refractive errors should be the highest priorities for international public health services in eye care and eye health.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.